One teacher said he administered about a dozen testlets, and instead of taking four days at the end of the year for testing, ...

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. A new 3-minute in-office test is offering a critical window for early detection.

Discover the new EsoGuard test, touted as a non-invasive method for early detection of esophageal cancer that offers hope for improved prognosis and treatment.

A new esophageal cancer test helps patients detect precancerous conditions early and avoid invasive procedures.

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study from ...

Additionally, ProPhase Labs announced that Mayo Clinic's Dr. Chris Hartley has submitted a paper on their B-Smart Esophageal Cancer Test, highlighting its potential for commercialization.

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment ...

This sixth article in a seven part series presents the Core GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to summary of findings tables. These tables provide ...

The TissueCypher Barrett’s Esophagus test is indicated for use in patients with endoscopic biopsy confirmed BE that is graded non-dysplastic (NDBE), indefinite for dysplasia (IND) or low-grade ...

About TissueCypher Barrett’s Esophagus Test The TissueCypher Barrett’s Esophagus test is Castle’s precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or ...